Related Experiment Video
Updated: Sep 20, 2025

09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
718
Exploiting the endothelial-immune axis to improve radiotherapy efficacy
Olivier Guipaud1, Claire Lago1, Lucie Portier1
1Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE, SERAMED, LRMed, 92260 Fontenay-aux-Roses, France.
The British Journal of Radiology
|May 26, 2025
Summary
Radiation significantly alters blood vessel endothelial cells, impacting tumor response and side effects. Understanding these changes is key to improving radiotherapy by targeting endothelial cells for better immune recruitment.
Area of Science:
- Oncology
- Immunology
- Vascular Biology
Background:
- The immune system is critical for tumor control and response to radiotherapy.
- Endothelial cells form a barrier and regulate immune cell traffic, but their function is altered by irradiation.
- Radiation-induced endothelial changes influence tumor response and normal tissue toxicity.
Purpose of the Study:
- To elucidate the impact of radiation on vascular endothelium in vivo.
- To understand the role of endothelial cells in regulating immune cell recruitment post-irradiation.
- To explore novel therapeutic strategies targeting endothelial cells for enhanced radiotherapy.
Main Methods:
- Utilizing advanced analytical technologies like single-cell RNA sequencing and spatial transcriptomics.
- Analyzing molecular responses and cell-cell interactions in irradiated animal models.
- Investigating irradiated human patient samples.
Main Results:
- Radiation profoundly alters endothelial cell function, affecting immune infiltration in tumors and normal tissues.
- Endothelial cells become more adhesive, promoting cell migration and immune cell infiltration.
- Single-cell analysis reveals new endothelial cell types and pathways involved in radiation response.
Conclusions:
- Targeting endothelial cells offers a promising strategy to improve radiotherapy's therapeutic gain.
- Understanding radiation-induced endothelial changes is crucial for mitigating adverse effects and enhancing anti-tumor immunity.
- Endothelial cell-mediated immune recruitment presents a potential target for modulating treatment outcomes.
Related Concept Videos
Tumor Immunotherapy
677
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K

